Clinical Trials Directory

Trials / Unknown

UnknownNCT03377868

Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, devastating, neurodegenerative disease characterized by the loss of cortical, brain stem, and spinal motor neurons. Visual evoked potentials studies in patients with ALS suggest visual pathway involvement. Optic coherence tomography (OCT) is a non-invasive cross-sectional imaging modality measuring the optical reflections in biological tissues. The main objective of this observational cohort study is to explore the correlation between changes on OCT retinal parameters and and clinical disability as measured by the ALS Functional Rating Scale (ALS-FRS-r) in patients with ALS at baseline, 3 and 6 months. A secondary objective is to explore the correlation between changes in retinal OCT parameters and pulmonary function tests (FVC and FEV1) in this cohort of patients with ALS. A parallel cohort of healthy age and sex matched subjects will participate as controls to obtain reference values of their retinal layers' thickness at baseline, 3 and 6 months.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptic coherence tomographyOptic coherence tomography measures retinal layer thickness, macular volume , and cell inner plexiform layer.
DIAGNOSTIC_TESTPulmonary function testPulmonary function test measures forced vital capacity and forced expiratory volume in one second.

Timeline

Start date
2018-01-03
Primary completion
2018-07-28
Completion
2018-09-28
First posted
2017-12-19
Last updated
2017-12-19

Source: ClinicalTrials.gov record NCT03377868. Inclusion in this directory is not an endorsement.